The combined ratio has consistently remained below 90% for the past five quarters, with the exception of Q4 2024's spike to 99.4%, which appears to be an anomaly. The loss ratio of 65.9% in Q2 2026 is the lowest in the observed period, suggesting favorable loss cost trends or reserve releases. However, the expense ratio of 22.6% is elevated compared to the 19-20% range seen in prior quarters, which may indicate higher acquisition costs or one-time expenses. Investors should monitor whether the low loss ratio is sustainable or if it reflects benign catastrophe activity.

The ROE of 2.9% in Q2 2026 is modest but stable, reflecting a combination of underwriting profits and investment income. The Q4 2024 ROE of 0.2% highlights the impact of elevated catastrophe losses or reserve charges, which can distort quarterly profitability. The low ROE relative to peers like Travelers (25.6%) and Hartford (23.0%) suggests that CNA's return generation is structurally lower, possibly due to its conservative investment portfolio and higher expense base. The sustainability of this ROE depends on maintaining combined ratios below 95% and continued investment income tailwinds from higher interest rates.

The expense ratio has been volatile, with Q1 2026 showing 32.7% and Q4 2024 showing 30.4%, while other quarters hover around 20%. This volatility may indicate timing of policy acquisition costs or one-time items, but it complicates trend analysis. The elevated expense ratio in Q1 2026 could be due to higher commission expenses or deferred acquisition cost adjustments. Compared to peers, CNA's expense ratio is not directly comparable, but the volatility suggests less operational efficiency stability. Investors should monitor whether the expense ratio normalizes to the low-20s range or if structural cost pressures emerge.

The debt-to-equity ratio of 0.27% is negligible, indicating that CNA relies almost entirely on equity and insurance float to fund operations. This conservative capital structure provides significant financial flexibility, but it also suggests that the company may not be optimizing its capital structure to enhance ROE. The low leverage, combined with a strong balance sheet, positions CNA to withstand adverse underwriting cycles or pursue strategic opportunities. However, the high dividend yield of 7.9% may indicate that the company is returning excess capital rather than deploying it for growth, which could limit future expansion.

CNA's P/B of 1.15 is substantially lower than its primary peers, which may reflect the Loews ownership structure and limited public float, leading to a liquidity discount. The market appears to be pricing in concerns about the legacy LTC run-off and potential reserve inadequacy, despite the strong underwriting performance. The P/E of 10.44 is also below the peer average, suggesting that the market is not giving full credit to CNA's earnings quality. This discount may be justified by the perceived complexity of the LTC liabilities and the influence of Loews on capital allocation, but it also presents potential upside if the market re-rates the stock.